Murphy S S - OmicsDI

Show results for

Unknown (5681)
Transcriptomics (144)
Proteomics (140)
Genomics (51)
Metabolomics (36)
Genomic (2)
Other (2)

Organisms

Chlamydomonas reinhardtii (131)
Marchantia polymorpha subsp. ruderalis (131)
Methylocystis sp. (131)
Porites pukoensis (131)
Bothrops insularis (131)
Bothrops jararaca (131)
Bothrops jararacussu (131)
Bothrops cotiara (131)
Streptomyces coelicolor (131)
Burkholderia ubonensis MSMB22 (131)
Pseudomonas aeruginosa PA103 (131)
Artibeus jamaicensis (131)
Homo sapiens (101)
Mus musculus (61)
Rattus norvegicus (7)
Caenorhabditis elegans (5)
Macaca mulatta (2)
Bos taurus (2)
Saccharomyces cerevisiae (2)
Danio rerio (2)
Cryptomys hottentotus hottentotus (1)
Pan troglodytes (1)
Bos indicus (1)
Zea mays (1)
Geobacter sulfurreducens (1)
Staphylococcus aureus (1)
Solanum tuberosum (1)
Sus scrofa (1)
Drosophila melanogaster (1)
Arabidopsis thaliana (1)

Organisms

Homo sapiens (2)
Caenorhabditis elegans (1)
Mus musculus (1)

Repository

biostudies-arrayexpress (154)
pride (131)
MetaboLights (35)
EGA (34)
MassIVE (6)
ENA (5)
dbGaP (2)
geo (2)
GPMDB (2)
GNPS (1)
iProX (1)
jPOST (1)
PanoramaPublic (1)

Tissue

Cell culture (20)
Brain (13)
Epithelial cell (11)
Whole body (7)
Fibroblast (7)
Permanent cell line cell (5)
Neutrophil (5)
Bone marrow (4)
Cell suspension culture (4)
Blood (4)
Prostate adenocarcinoma cell line (3)
Epithelial cell of prostate (3)
Skin (3)
Macrophage (3)
Skeletal muscle (3)
Blood plasma (3)
B cell (3)
Monocyte (3)
Bone marrow macrophage (2)
Glomerular visceral epithelial cell (2)
Leukocyte (2)
Heart (2)
Root (2)
Spleen (2)
Colon (2)
T cell (2)
Endometrium epithelium (1)
Neurohypophysis (1)
Culture medium (1)
Raphe nuclei (1)

Disease

Neuroblastoma (3)
Prostate carcinoma (3)
Glioblastoma (3)
Colon cancer (3)
Not Available (2)
Pancreatic ductal adenocarcinoma (2)
Cervix carcinoma (2)
Parkinson's disease (2)
Brain cancer (2)
Myocardial ischemia (2)
HPV positive (1)
Melanoma (1)
Osteosarcoma (1)
Female infertility of uterine origin (1)
Bloom syndrome (1)
Low birth weight (1)
Fibrolamellar carcinoma (1)
Fibrosarcoma (1)
Neurological dysfunction (1)
Avian influenza (1)
Mental depression (1)
Kidney disease (1)
Multiple myeloma (1)
Lymphoma (1)
Adult respiratory distress syndrome (1)
Cardiovascular system disease (1)
Acute myeloid leukemia (1)
Malignant neoplasm of ovary (1)
Type 2 diabetes mellitus (1)
Breast cancer (1)

Technology Type

Mass Spectrometry (131)
Shotgun proteomics (70)
Mass spectrometry (34)
Bottom-up proteomics (24)
Affinity purification coupled with mass spectrometry proteomics (14)
Gel-based experiment (12)
Data-dependent acquisition (9)
Data-independent acquisition (8)
SWATH MS (5)
Top-down proteomics (4)
Chemical cross-linking coupled with mass spectrometry proteomics (3)
ILLUMINA, Illumina HiSeq 4000, Illumina HiSeq 2500 (1)
Affymetrix OncoScan FFPE Express (1)
Illumina HiSeq 2500, ILLUMINA, Illumina MiSeq (1)
Illumina MiSeq (1)
Mass spectrometry assay (1)
SRM/MRM (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (16)
Liquid Chromatography MS - negative - reverse phase (11)
NextSeq 500 (10)
Illumina HiSeq 2000 (4)
API 4000 QTRAP (AB Sciex) (4)
Direct infusion MS - negative (3)
Direct infusion MS - positive (3)
Liquid Chromatography MS - negative - hilic (3)
Illumina Genome Analyzer IIx (2)
Instrument (2)
Q Exactive HF (2)
DNBSEQ-G400 FAST (1)
DNA Microarray Scanner (Model G2505C, Agilent Technologies) (1)
N/A (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 4000 (1)
LTQ FT (1)
MaXis (1)
Autoflex Speed LRF (1)
Autoflex (1)
LTQ (1)
Q Exactive HF-X (1)
Liquid Chromatography MS -neg - hilic (1)
Liquid Chromatography MS – pos - hilic (1)
LTQ XL (Thermo Scientific) (1)
Direct infusion MS - (1)
Gas Chromatography MS - Positive (GC-MS (Positive)) (1)
Liquid Chromatography Tandem MS (LC-MS/MS) (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)
LTQ Orbitrap XL (Thermo Scientific) (1)

Publication Date

2015 (27)
2025 (24)
2021 (23)
2022 (22)
2024 (21)
2018 (20)
2016 (20)
2014 (20)
2010 (20)
2023 (19)
2013 (16)
2008 (16)
2012 (15)
2020 (14)
2011 (13)
2026 (11)
2019 (10)
2009 (9)
2017 (7)
2007 (4)
2006 (1)

CHEBI ID

CHEBI:15843 (7)
CHEBI:34494 (6)
CHEBI:63966 (5)
CHEBI:63969 (5)
CHEBI:19138 (5)
CHEBI:72643 (5)
CHEBI:64017 (5)
CHEBI:60943 (5)
CHEBI:15650 (5)
CHEBI:15647 (5)
CHEBI:72606 (5)
CHEBI:15547 (5)
CHEBI:15555 (5)
CHEBI:15551 (5)
CHEBI:15553 (5)
CHEBI:28158 (5)
CHEBI:16196 (5)
CHEBI:17351 (5)
CHEBI:30769 (5)
CHEBI:63974 (4)
CHEBI:72853 (4)
CHEBI:63981 (4)
CHEBI:15646 (4)
CHEBI:85700 (4)
CHEBI:52449 (4)
CHEBI:27485 (4)
CHEBI:16978 (4)
CHEBI:53487 (4)
CHEBI:72665 (4)
CHEBI:38299 (4)

Metabolite Name

Arachidonic acid (5)
12,13-DiHOME (5)
19(20)-EpDPE (5)
9-HODE (5)
12-HETE (5)
8-HETE (5)
15-HETE (5)
5-HETE (5)
PGA2 (5)
11-HETE (5)
PGD2 (5)
PGE2 (5)
9,10-DiHOME (5)
5,6-DiHETrE (4)
PGJ2 (4)
17(18)-EpETE (4)
14,15-DiHETrE (4)
11,12-DiHETrE (4)
12,13-EpOME (4)
9,10-EpOME (4)
19(20)-DiHDPA (4)
5,6-EET (4)
13-oxoODE (4)
HXB3 (4)
14-HDoHE (4)
12-HEPE (4)
10-HDoHE (4)
15-HETrE (4)
13-HOTrE (4)
13-HODE (4)

First Public Date

2026 (1)
2024 (1)
2020 (1)
2015 (1)
2014 (1)

Modification

Not available (2)

Study type

Transcription profiling by array (103)
RNA-seq of coding RNA (24)
ChIP-seq (11)
Comparative genomic hybridization by array (2)
Methylation profiling by array (2)
RNA-seq of non coding RNA (2)
ChIP-chip by tiling array (1)
One-color microarray (1)
Human - High-throughput sequencing (1)
Animal - High-throughput sequencing (1)
Cell line - High-throughput sequencing (1)
ChIP-chip by array (1)
Other (1)
RNA-seq of coding RNA from single cells (1)
Methylation profiling by high throughput sequencing (1)
RNA-seq of total RNA (1)

Release Date

2022 (654)
2021 (590)
2023 (588)
2025 (525)
2024 (466)
2020 (452)
2018 (374)
2019 (342)
2017 (289)
2016 (264)
2015 (263)
2014 (209)
2013 (154)
2012 (131)
2011 (125)
2010 (98)
2009 (76)
2026 (56)
2008 (55)
2006 (30)
2007 (28)
2005 (20)
2004 (16)
2003 (9)
2002 (7)
2000 (4)
2001 (3)
1998 (3)
1999 (2)
1997 (1)

Lab affiliation

University of Warwick (7)
Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, London, W12 0BZ, UK The Francis Crick Institute, London, NW1 1AT, UK (4)
CRUK - Beatson Institute for Cancer Research - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (4)
Department of Pathology, Dalhousie University (3)
Sir William Dunn School of Pathology, University of Oxford (3)
School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, United Kingdom (2)
Dalhousie University (2)
Foetal Exposure Group School of Clinical Sciences University of Bristol United Kingdom (2)
School of Biosciences, University of Sheffield, Sheffield, UK (2)
The University of Melbourne (2)
BBSRC Discovery Fellow & BMC Microbiome Managing Editor Arthur Willis Environmental Research Centre University of Sheffield Sheffield S10 1AE (1)
Newcastle University Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK (1)
Bristol Renal University of Bristol UK (1)
BioOrganic Mass Spectrometry laboratory (LSMBO) Institut Plurisciplinaire Hubert Curien University of Strasbourg. France (1)
Laboratory of Biochemistry and Genetics, NIDDK, NIH, USA (1)
IUSM Center for Proteome Analysis, Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN (1)
James McGill Professor of Neurology and Neurosurgery and Anatomy and Cell Biology Montreal Neurological Institute-Hospital McGill, Montreal CANADA (1)
Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland (1)
Department of Chemistry, Imperial College London, Molecular Research Science Hub, 80 Wood Lane, London W12 0BZ, United Kingdom. The Francis Crick Institute, 1 Midland Road, London NW1 1AT, United Kingdom. (1)
TDI/CMD nuffield department of medicine, University of Oxford (1)
Departments of Pathology and Microbiology & Immunology, Dalhousie University, Halifax, Canada. (1)
Centre for Inflammation research, Institute for Regeneration and Repair, University of Edinburgh (1)
1Department of Molecular Biology & 2LSI Genomics, Princeton University (1)
Children's Medical Research Institute, Faculty of Medicine and Health, Westmead, NSW, Australia (1)
Department of Biochemistry, Monash University, Clayton,3168, Australia (1)
1. Garvan Institute of Medical Research, Cancer Ecosystems Program, and The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia. 2. School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales (UNSW), Kensington, Sydney, New South Wales, Australia. (1)
Departamento de Biología Molecular, Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid (1)
Associate Professor Microbiology and Immunology Department Upstate Medical University Weiskotten Hall Rm. 2273 766 Irving Avenue Syracuse, NY 13210 Tel 315.464.5870 (1)
National Institute for Cellular Biotechnology, Dublin City University (1)
Head, Inflammation Division Professor and NHMRC Leadership Fellow Walter and Eliza Hall Institute of Medical Research 1G Royal Parade Parkville, VIC 3052, Australia (lab head) (1)

Tags

xref:PubMed:39375550 (1)
xref:PubMed:33009389 (1)

Previous page
1 / 606
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 606
Next page

Sort by:

Relevance

Page size

Protein S-Nitrosylation of host and viral proteins upon fibroblast infection with Human Cytomegalovirus

Human Cytomegalovirus (HCMV) is a ubiquitous pathogen that has co-evolved with its host and in doing so, is highly efficient in undermining antiviral responses that limit successful infections. As a result, HCMV infections are highly problematic in individuals with weakened or underdeveloped immune ...

ORGANISM(S): Homo sapiens (Human)

2020-07-03 | PXD019208 | Pride

Expression data from C57BL/6J and MRL/MpJ hearts following acute myocardial infarction

The Murphy Roth Large (MRL) mouse, a strain capable of regenerating right ventricular myocardium, has a high post-myocardial infarction (MI) survival rate compared with C57BL6/J (C57) mice. The biological processes responsible for this survival advantage are unknown. We compared acute post-MI gene e...

ORGANISM(S): Mus musculus

2010-05-27 | E-GEOD-19322 | biostudies-arrayexpress

Combined Neuropeptide S and D-Cycloserine Augmentation Prevents the Return of Fear in Extinction-Impaired Rodents: Advantage of Dual versus Single Drug Approaches.

Not available

S-EPMC4926792 | biostudies-literature

Comparison of S. boulardii cells in H2O vs. S. boulardii cells in H2O+HCl

We sought to better understand the mechanism of acid-induced cell death in Saccharomyces boulardii--a probiotic yeast routinely used to prevent and treat gastrointestinal disorders. To do this we generated microarray gene expression profiles of S. boulardii cells cultured in an acidic environment. T...

ORGANISM(S): Saccharomyces boulardii

2013-01-04 | E-GEOD-43271 | biostudies-arrayexpress

Additive cardioprotection by pharmacological postconditioning with hydrogen sulfide and nitric oxide donors in mouse heart: S-sulfhydration vs. S-nitrosylation.

Not available

S-EPMC4798049 | biostudies-literature

Benzene oxide is a substrate for glutathione S-transferases.

Not available

S-EPMC4695229 | biostudies-literature

Characterization of the sex-dependent myocardial S-nitrosothiol proteome.

Not available

S-EPMC4796614 | biostudies-literature

Staphylococcus aureus responds to physiologically relevant temperature changes by altering its global transcript and protein profile

Staphylococcus aureus is an opportunistic pathogen that colonizes the anterior nares of 30-50% of the population. Colonization is most often asymptomatic, however, self-inoculation can give rise to potentially fatal infections of the deeper tissues and blood. Like all bacteria, S. aureus is able to ...

ORGANISM(S): Staphylococcus aureus (strain USA300)

2021-03-10 | PXD023039 | Pride

Staphylococcus aureus temperature

Power-duration relationship comparison in competition sprint cyclists from 1-s to 20-min. Sprint performance is more than just peak power.

Not available

S-EPMC10218722 | biostudies-literature

Characterization of potential S-nitrosylation sites in the myocardium.

Not available

S-EPMC3075037 | biostudies-literature

Previous page
1 / 606
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 606
Next page

Sort by:

Relevance

Page size

6056 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Modification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets